Placeholder Banner

Industrial Biotechnology at 2018 International Convention

May 30, 2018
The 2018 BIO World Congress on Industrial Biotechnology is quickly approaching, but before the partnering begins in Philadelphia BIO will be focusing on industrial biotechnology at the 2018 International Convention in Boston, June 4-7, 2018.

Programming at BIO’s International Convention will include sessions on Biofuels & Renewable Chemicals on Tuesday, June 5 starting at 11 a.m. Here’s a rundown for what to expect for each program:

Advances in Renewable Chemicals

11 am – noon, Room 255, Level 2

Renewable chemical companies are using new techniques – including synthetic biology and automation – to rapidly move from initial target identification to production of a desired renewable chemical. Several renewable chemical companies will present new methods to improve efficiency and efficacy in renewable chemical manufacturing. Panelists include:

Moderator: Kevin Jarrell, CEO, Modular Genetics


  • Stephan Herrera, VP, Evolva

  • Jason Kelly, CEO, Ginkgo Bioworks

  • John Shaw, President NA, Itaconix Corporation

Sustainable Aviation Fuel Taking Off!

3 – 4 pm, Room 255, Level 2

In May 2018, Boeing successfully flew the first commercial jet on 100 percent biofuel, flying from Seattle to Memphis and back. In this session, a panel of experts will discuss how biofuels are transforming the aviation industry and what the future holds. Panelists include:

Moderator: Todd Campbell, Development Advisor, CC: Clean Economy Works


  • Hank Krakowski, Director – Sustainable Aviation, Agrisoma Biosciences, Inc.

  • Jim Macias, President and CEO, Fulcrum BioEnergy

  • Chris Tindal, Assistant Director, Commercial Aviation Alternative Fuels Initiative

Designing Renewable Specialty Chemicals as Pharmaceutical Intermediates from Synthetic Biology

4:15 pm – 5:15 pm, Room 255, Level 2

Suppliers of active pharmaceutical ingredients (APIs) are looking to reduce cost and shorten time to market. As pharmaceutical manufacturers find their margins under pressure, they continue to look for ways to reduce cost through partnerships with industrial biotechnology companies that develop novel metabolic pathways to quality pharmaceutical intermediates. Panelists include:

Moderator: Brian Baynes, CEO, MODO Global


  • Emmanuel Petiot, CEO, DEINOVE

  • Christine Santos, CTO, Manus BIO

  • Tom Stephenson, CCO, Zymergen

  • Andrey Zarur, Ph.D., CEO, Greenlight Biosciences

In addition, BIO will be hosting a panel to discuss cellular agriculture and how Industrial Biotechnology is brewing protein! Panelists include:

Moderator: Vince Sewalt, Sr. Director, Product Stewardship & Regulatory, DuPont Industrial Biosciences


  • Isha Datar, Executive Director, New Harvest

  • Eric Schulze, VP. Product and Regulation, Memphis Meats

  • Mike Selden, CEO, Finless Foods

For a full rundown of industrial biotechnology and other programming visit For more information about the 2018 BIO International Convention visit